secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001493152-24-019232
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim Q1 revenue up 25% sequentially to $16.8M; net loss widens to $2.9M
------------------------------------------------------------------------

- Net revenue $16.8M, up 25% sequentially; GAAP net loss $2.9M vs $1.4M loss in Q4 2023.
- Adjusted EBITDA negative $1.6M vs positive $0.2M in prior quarter.
- Secured design awards with every tier-one carrier in US and Canada for next-gen rugged smartphone.
- Advanced 13 carrier awards toward summer 2024 launch; addressable market expands from $400M to $52B.
- Ended quarter with $9.3M cash; raised $3.85M equity at 126% premium to April 26 closing price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315224019232/0001493152-24-019232-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315224019232/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-019232

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer